Moderation of doxorubicin-induced nephrotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens

Catherine C Ikewuchi; Mercy O Ifeanacho; Jude C Ikewuchi

doi:10.1097/j.pbj.0000000000000129

. 2021 Feb 11;6(1):e129. doi: 10.1097/j.pbj.0000000000000129

Moderation of doxorubicin-induced nephrotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens

Catherine C Ikewuchi ^a, Mercy O Ifeanacho ^b,^∗, Jude C Ikewuchi ^a

PMCID: PMC8055491 PMID: 33884325

Abstract

Background:

The major draw-back of doxorubicin's use in chemotherapy is its toxicity on various organs including the kidneys. This study investigated the potential protective role of aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens against nephrotoxicity induced by doxorubicin.

Methods:

To this end, their impact on plasma biomarkers of kidney function, as well as renal lipid profile, biomarkers of oxidative stress, electrolyte profile and activities of renal ATPases was monitored in doxorubicin treated rats. Metformin (250 mg/kg body weight, orally) and the extracts (50, 75 and 100 mg/kg, orally) were daily administered for 14 days; while nephrotoxicity was induced with doxorubicin (15 mg/kg, intra-peritioneally), once on the 12th day of study.

Results:

The plasma concentrations of creatinine, and urea; as well as the renal malondialdehyde, cholesterol, calcium and sodium concentrations in the Test control, were significantly (P < .05) higher than those of all the other groups. However, the renal concentrations of ascorbic acid, chloride, magnesium and potassium, and the renal activities of catalase, glutathione peroxidase superoxide dismutase, Ca²⁺-ATPase, Mg²⁺-ATPase and Na⁺,K⁺-ATPase in the Test control were significantly (P < .05) lower than those of all the other groups.

Conclusions:

Pre-treatment with the extracts and metformin boosted endogenous antioxidants, and prevented doxorubicin-induced renal damage, as indicated by the attenuation of doxorubicin-induced renal oxidative stress, as well as the attenuation of doxorubicin-induced adverse alterations in renal cholesterol, ATPases and electrolyte balance, and plasma biomarkers of kidney function, and keeping them at near-normal values.

Keywords: ATPases, cholesterol, Chromolaena odorata, doxorubicin, electrolytes, kidney function markers, oxidative stress, Tridax procumbens

Introduction

Doxorubicin's toxicity affects various organs including the kidneys.^1–6 Numerous studies suggests that doxorubicin-induced toxicity may be a consequence of oxidative stress, which results in oxidation and cross-linking of cellular thiols and membrane lipid peroxidation.¹ Doxorubicin-induced oxidative stress in renal tissues is characterized by elevated malondialdehyde (a marker of lipid peroxidation) and lowered reduced glutathione levels^4,7,8; as well as lowered activities of catalase,² glutathione peroxidase and superoxide dismutase.^3,8,9 In addition to oxidative damage, doxorubicin toxicity also induces inflammatory changes in kidney tissues.^8,10 Doxorubicin-induced nephrotoxicity causes increased capillary porousness and glomerular shrinking.⁸ It is characterized by increased plasma levels of creatinine, urea^2,7 and uric acid,⁷ and increased plasma lactate dehydrogenase activity⁷; as well as reduced renal Ca²⁺-ATPase, Mg²⁺-ATPase and Na⁺,K⁺-ATPase activities.^1,11

Studies suggest that the healing effect of metformin (a widely used anti-hyperglycaemic drug for type 2 diabetes mellitus) is facilitated by its effect on adenosine monophosphate-activated protein kinase in tissues.^12,13 Numerous studies show that metformin lowers intracellular reactive oxygen species and regulates mitochondrial function.^12,14,15 The beneficial effects of metformin on renal injury with different aetiologies have been reported,¹⁶ including the alleviation of diabetes-associated renal injury.^12,17 Metformin ameliorates tubular injury by regulating oxidative stress and restoring biochemical alterations in renal tubules,¹² as well as by anti-inflammatory and anti-apoptotic activities.^14,18

Studies have shown that doxorubicin-induced oxidative damage to the kidney can be mitigated or prevented by treatment with natural antioxidants;^9,10,19 hence necessitating the investigation of various natural sources of antioxidants. The leaves of Chromolaena odorata and T procumbens are rich in potent antioxidants such as allicin, caffeic acid, ellagic acid, epicatechin, lycopene, naringenin, quercetin and silymarin.^20–26 These antioxidants have been variously reported to exert nephro-protective effects via attenuation of oxidative stress in the kidney, induced by doxorubicin, oxytetracycline, cadmium or gentamicin.^{2,5,8,9,10,19,27–32}

Various studies have reported the anti-hypertensive, antidyslipidaemic, weight reducing,^{22,24,25,33–39} hepato-protective and anti-diabetic activities of leaf-extracts of C odorata and T procumbens.^21,40–44 Their anticancer^45-47 and antioxidant^48–52 activities have also been reported. In this study the impact of aqueous leaf-extracts of C odorata and T procumbens on doxorubicin-induced renal damage was investigated in Wistar rats.

Materials and methods

Procurement of materials

Fresh samples of C odorata and T procumbens were collected from within the University of Port Harcourt, and were duly identified as earlier reported.^{20–26,34–39,41,53} Forty-five Wistar rats (weight 120–190 g) were obtained from the Animal House of Department of Pharmacology, University of Port Harcourt, Nigeria. All chemicals used were of analytical grade and products of Sigma-Aldrich, St Louis, MO, USA. The cholesterol, triglyceride and calcium kits were products of Randox Laboratories Ltd, County Antrim, UK; the sodium and potassium kits were products of Atlas Medical, Cowley Rd, Cambridge, UK; while the chloride, magnesium, creatinine and urea kits were products of Agappe Diagnostics Switzerland, GmbH.

Preparation of extracts

The leaves were rid of dirt. Then 6 kg of C odorata and 5.5 kg of T procumbens were macerated. The resultant extracts were dried in a water bath, and their residues (127 and 116 g, respectively) were stored for use in the assay. The resultant leaf-extracts of C odorata and T procumbens (hereinafter referred to as COLE and TPLE, respectively), were weighed, reconstituted in distilled water and administered to the experimental animals, according to their groups’ dosages and their individual weights.

Experimental design and sample collection

All experimental procedures in this study were performed in accordance with the ethical guidelines for investigations using laboratory animals, and complied with the guide for the care and use of laboratory animals.⁵⁴ The animals were weighed and sorted into 9 groups of five animals each, so that their average differences in weights were <3 g.⁵⁵ They were housed in cages at the Department of Pharmacology, and allowed water and feed ad libitum. After 1 week acclimatization, the treatment commenced and lasted for 14 days. Diabetmin^TM (metformin HCl) (dissolved in distilled water) was orally administered daily at 250 mg/kg body weight to the Metformin group. The extracts were administered via the same route at 50 mg/kg to COLE-50mg (COLE) and TPLE-50mg (TPLE); 75 mg/kg to COLE-75mg (COLE) and TPLE-75mg (TPLE); and 100 mg/kg to COLE-100mg (COLE) and TPLE-100mg (TPLE). The Normal and Test control groups received distilled water in place of the extract.

On day 12, doxorubicin was dissolved in normal saline and intra-peritioneally injected (15 mg/kg), into all the groups, except the Normal control which was given normal saline instead. The doxorubicin dosage was adopted from Song et al.⁵⁶ The dosages of administration of C odorata extract was adopted and modified from Ikewuchi et al^22,24,25; that of T procumbens extract was from Ikewuchi et al^36,37; while that of metformin was from Zilinyi et al.⁵⁷

The animals were sacrificed on day 14, under chloroform anaesthesia and blood samples were collected into heparin bottles; their kidneys were harvested, and their weights and sizes were documented.²⁴ The blood samples were centrifuged at 1000 rpm for 10 min, and their plasma were removed and stored. The harvested organs were homogenized in distilled water (at 0.4 g per 5 mL), and the ensuing homogenates were stored for use in the assay. The kidney weights/sizes indices were determined using the formula below.⁵⁸

Kidney weight or size index (%) = \frac{Kidney weight (g) or kidney size (c m^{3})}{Body weight (g)} \times 100

Assay of biochemical parameters

The homogenates’ malondialdehyde concentrations were analysed according to the method of Gutteridge and Wilkins.⁵⁹ The “sample tubes” contained 1 mL of glacial acetic acid, 1 mL of 1% thiobarbituric acid solution and 0.2 mL of sample. They were read at 532 nm, after zeroing the spectrophotometer with a blank containing 0.2 mL of distilled water instead. The ascorbic acid contents were estimated by iodine titration.⁶⁰ Aliquot (1.0 mL) of the sample was added to 5 mL of reaction mix (31.746 mg% starch in 1.243% (v/v) HCl); and titrated with iodine solution, until the appearance of a permanent blue colour. Catalase activities were according to Beers and Sizer.⁶¹ The “sample tubes” contained 2.50 mL of hydrogen peroxide, and 2.70 mL of distilled water was used to zero the spectrophotometer and absorbance read at 420 nm, exactly 1 minute after adding 0.20 mL of the sample. The “reference” contained 0.20 mL of distilled water in place of the sample. Superoxide dismutase activities were according to Misra and Fridovich.⁶² The “sample tubes” contained 0.1 mL of sample, 1.25 mL of 0.05 M carbonate buffer. They were equilibrated at room temperature, and 1.5 mL of distilled water was used to zero the spectrophotometer and absorbance read at 520 nm, exactly 1 minute after adding 0.15 mL of 0.3 mM adrenaline. The “reference” contained 0.1 mL of distilled water in place of the sample. Glutathione peroxidase activities were according to Rotruck et al.⁶³ The assay mixture containing 0.5 mL of sodium phosphate buffer (0.1 M, pH 7.4), 0.1 mL of 10 mM sodium azide, 0.2 mL of 4 mM reduced glutathione, 0.1 mL of 25 mM hydrogen peroxide, 0.5 mL sample, and 0.6 mL distilled water was incubated at 37°C for 3 min, before adding 0.5 mL 10% TCA. After centrifugation, the residual glutathione contents of the supernatants, was determined by adding 0.5 mL of the supernatants, 4.0 mL of 0.3 M disodium hydrogen phosphate solution and 1 mL of 0.01 M DTNB reagent, and reading at 412 nm, against a reagent blank containing only 4.5 mL phosphate solution and 1 mL DTNB reagent. Half millilitre of the standard (4 mM glutathione solution) was treated in a similar way. The activities of the ATPases were determined by the method of Hesketh et al.⁶⁴ The quantity of inorganic phosphate was determined by the method of Fiske and Subbarow.⁶⁵ The homogenates’ protein contents were determined by Lowry method.⁶⁶

The calcium, chloride, cholesterol, magnesium, potassium, sodium and triglyceride contents of the homogenates were assayed according to the kits manufacturers’ instructions; except that homogenates were used instead of plasma. The assay procedures for the plasma creatinine and urea concentrations were according to the kits manufacturers’ instructions. The urea to creatinine ratio was calculated with the formula below.⁶⁷

U r e a / c r e a t i n i n e r a t i o = \frac{P l a s m a u r e a c o n c e n t r a t i o n (m m o l / L)}{P l a s m a c r e a t i n i n e c o n c e n t r a t i o n (m m o l / L)}

Determination of per cent protection

The per cent protection of the kidneys were calculated with the formula below.²¹

P e r c e n t p r o t e c t i o n = \frac{P a r a m e t e r_{t e s t c o n t r o l} - P a r a m e t e r_{t r e a t m e n t}}{P a r a m e t e r_{t e s t c o n t r o l} - P a r a m e t e r_{n o r m a l c o n t r o l}}

Statistical analysis of data

Statistical calculations were carried out with the Excel 2010 (Data Analysis Add-in) software. All data are expressed as mean ± standard error of the mean (SEM), and were analysed using 1-way analysis of variance (1-way ANOVA). Significant difference of the means was determined using a post-hoc analysis involving LSD (least significant difference) test; with P < .05 considered statistically significant.

Results

The effects of aqueous leaf-extracts of C odorata and T procumbens on the kidney weight and size indices of doxorubicin treated rats is presented in Figure 1. The kidney weight index and kidney size index of Test control were not significantly different from those of all the other groups, except TPLE-50mg. The renal malondialdehyde concentration of Test control was significantly (P < .05) higher than those of all the others (Table 1). The renal ascorbic acid concentration, and the renal catalase, glutathione peroxidase and superoxide dismutase activities of Test control were significantly (P < .05) lower than those of all the others (Table 1). The plasma concentrations of creatinine, urea and blood urea nitrogen of Test control were significantly (P < .05) higher than those of all the others (Fig. 2). However, the urea/creatinine ratio of Test control was significantly (P < .05) lower than those of COLE-100mg and TPLE-100mg, but not significantly different from the others.

Effects of aqueous leaf-extracts of *C odorata* and *T procumbens* on the kidney weight and size indices of doxorubicin treated rats. Values are mean ± SEM, n = 5 animals, per group. Bars in the same block with different superscript letters differ significantly at P < .05.

Table 1.

Effects of aqueous leaf-extracts of C odorata and T procumbens on renal biomarkers of oxidative stress of doxorubicin treated rats

Treatments	Malondialdehyde (μmol/mg protein)	Ascorbic acid (μg/mg protein)	Glutathione peroxidase (μmol/min/mg protein)	Superoxide dismutase (units/mg protein)	Catalase (μmol/min/mg protein)
Normal control	1.221 ± 0.108^a	18.881 ± 0.270^a	0.192 ± 0.004^a	0.503 ± 0.056^a	3.382 ± 0.118^a
Test control	1.894 ± 0.093^c	7.925 ± 0.030^c	0.137 ± 0.008^c	0.281 ± 0.032^c	1.646 ± 0.083^b
Metformin	1.157 ± 0.096^a,b	12.838 ± 0.222^d	0.210 ± 0.002^d	0.754 ± 0.042^b,d	3.412 ± 0.313^a
COLE-50mg	1.159 ± 0.062^a,b	15.324 ± 0.227^e	0.194 ± 0.007^a	0.554 ± 0.036^a	3.399 ± 0.281^a
COLE-75mg	1.122 ± 0.105^a,b	15.580 ± 0.248^e	0.171 ± 0.004^b,f	0.647 ± 0.038^d	2.664 ± 0.100^c
COLE-100mg	1.003 ± 0.059^a,b	9.331 ± 0.177^f	0.184 ± 0.007^a,f	0.787 ± 0.029^b	3.607 ± 0.104^a,d
TPLE-50mg	1.132 ± 0.047^a,b	9.402 ± 0.157^f	0.168 ± 0.002^b	0.687 ± 0.027^b,d	3.001 ± 0.231^a,c
TPLE-75mg	1.245 ± 0.140^a	8.603 ± 0.036^g	0.177 ± 0.003^b,e,f	0.736 ± 0.068^b,d	3.467 ± 0.086^a
TPLE-100mg	0.946 ± 0.085^b	10.687 ± 0.275^b	0.187 ± 0.002^a,e	0.719 ± 0.061^b,d	4.103 ± 0.238^d

Open in a new tab

Values are mean ± SEM, n = 5. Values in the same column with different superscript letters differ significantly at P < .05.

Impact of aqueous leaf-extracts of *C odorata* and *T procumbens* on plasma biomarkers of kidney function of doxorubicin treated rats. Values are mean ± SEM, n = 5. Bars in the same block with different superscript letters differ significantly at P < .05. ^∗Has no unit.

The renal cholesterol concentration of Test control was significantly (P < .05) higher than those of all the others except Metformin (Table 2). The renal triglyceride concentration of Test control was not significantly different from those of all the others. The Mg²⁺-ATPase, Na⁺,K⁺-ATPase and Ca²⁺-ATPase activities of Test control were significantly (P < .05) lower than those of all the other groups (Table 2). As shown in Table 3, the renal chloride, magnesium and potassium concentrations of Test control were significantly (P < .05) lower; while the calcium and sodium concentrations were significantly (P < .05) higher than those of all the other groups. The administration of the extracts and metformin prevented the doxorubicin-induced renal damage, as indicated by the attenuation of doxorubicin-induced adverse alterations in the plasma markers of renal functions/integrity, and renal markers of oxidative stress, and caused a subsequent protection towards normalization. The administration of the extracts also prevented the doxorubicin-induced reduction in activities of renal ATPases, and caused a subsequent protection towards normalization. These protections have been presented in Table 4 in the form of per cent protection of the parameters by the different test treatments.

Table 2.

Effects of aqueous leaf-extracts of C odorata and T procumbens on renal lipid profiles and ATPase activities of doxorubicin treated rats

	Lipid profile (mmol/mg protein)		ATPase activities (mmol/min/mg protein)

Treatments	Triglyceride	Cholesterol	Mg²⁺-ATPase	Na⁺,K⁺-ATPase	Ca²⁺-ATPase
Normal control	0.237 ± 0.043^a	0.231 ± 0.056^a	3.721 ± 0.353^a	15.881 ± 1.601^a	1.468 ± 0.081^a,f
Test control	0.306 ± 0.079^a	0.459 ± 0.052^b	1.965 ± 0.129^c	7.973 ± 1.250^c	0.697 ± 0.058^c
Metformin	0.250 ± 0.023^a	0.401 ± 0.022^b,c	3.555 ± 0.212^a	28.399 ± 1.210^b	1.713 ± 0.068^d
COLE-50mg	0.212 ± 0.048^a	0.219 ± 0.043^a	13.060 ± 0.930^d	16.503 ± 1.928^a	1.143 ± 0.059^b,e
COLE-75mg	0.216 ± 0.025^a	0.185 ± 0.045^a	4.257 ± 0.292^a	19.626 ± 2.474^a	1.656 ± 0.085^d,f
COLE-100mg	0.169 ± 0.051^a	0.252 ± 0.059^a,c	8.326 ± 0.481^f	16.178 ± 2.033^a	1.012 ± 0.087^b
TPLE-50mg	0.241 ± 0.040^a	0.243 ± 0.049^a	5.565 ± 0.182^b	17.365 ± 2.198^a	1.297 ± 0.051^a,e
TPLE-75mg	0.195 ± 0.051^a	0.174 ± 0.059^a	4.192 ± 0.409^a	16.608 ± 2.579^a	1.908 ± 0.086^d
TPLE-100mg	0.233 ± 0.050^a	0.202 ± 0.070^a	5.853 ± 0.499^b	21.522 ± 2.274^a	1.420 ± 0.074^a

Open in a new tab

Values are mean ± SEM, n = 5. Values in the same column with different superscript letters differ significantly at P < .05.

Table 3.

Effects of aqueous leaf-extracts of C odorata and T procumbens on renal electrolytes profiles of doxorubicin treated rats

Treatments	Calcium (μg/mg protein)	Chloride (μEq/mg protein)	Magnesium (μg/mg protein)	Potassium (μmol/mg protein)	Sodium (μEq/mg protein)
Normal control	9.557 ± 0.197^a,d	11.307 ± 0.262^a	3.894 ± 0.026^a	0.799 ± 0.020^a	7.090 ± 0.831^a,c
Test control	13.867 ± 0.487^c	6.877 ± 0.076^c	3.072 ± 0.027^b	0.416 ± 0.017^c	12.449 ± 0.443^b
Metformin	9.172 ± 0.462^a,b,d	8.914 ± 0.266^d	5.876 ± 0.030^c	0.474 ± 0.010^d	7.138 ± 0.163^a,c
COLE-50mg	10.027 ± 0.434^d	12.882 ± 0.387^e	5.083 ± 0.041^d	0.561 ± 0.012^e	8.017 ± 0.220^a
COLE-75mg	8.644 ± 0.508^a,b	8.597 ± 0.338^d	4.626 ± 0.040^e	0.471 ± 0.016^d	7.521 ± 0.144^a,c
COLE-100mg	8.163 ± 0.326^a	14.603 ± 0.323^f	4.351 ± 0.024^f	0.606 ± 0.009^e,f	8.019 ± 0.382^a
TPLE-50mg	8.197 ± 0.480^a	13.191 ± 0.362^b,e	5.250 ± 0.047^g	0.734 ± 0.029^g	8.107 ± 0.315^a
TPLE-75mg	8.176 ± 0.406^a	8.245 ± 0.071^d	3.732 ± 0.026^h	0.685 ± 0.008^b,g	6.516 ± 0.188^c
TPLE-100mg	8.718 ± 0.263^a,b	14.040 ± 0.442^b,f	5.056 ± 0.041^d	0.646 ± 0.027^b,f	8.161 ± 0.326^a

Open in a new tab

Values are mean ± SEM, n = 5. Values in the same column with different superscript letters differ significantly at P < .05.

Table 4.

Per cent protection of the kidneys by the extracts

Parameter	Metformin	COLE-50mg	COLE-75mg	COLE-100mg	TPLE-50mg	TPLE-75mg	TPLE-100mg
Plasma
Creatinine	141.2 ± 0.9^a	52.9 ± 9.3^b	82.4 ± 13.2^b	88.2 ± 21.6^b	76.5 ± 25.3^b	94.1 ± 15.0^b	152.9 ± 7.2^a
Urea	176.2 ± 1.8^a	32.0 ± 6.0^c	86.3 ± 3.1^d	21.0 ± 5.9^c	155.0 ± 2.4^b	85.5 ± 5.6^d	25.8 ± 4.3^c
Blood urea nitrogen	176.2 ± 1.8^a	32.0 ± 6.0^c	86.3 ± 3.1^d	21.0 ± 5.9^c	155.0 ± 2.4^b	85.5 ± 5.6^d	25.8 ± 4.3^c
Urea nitrogen/creatinine ratio	-758.1 ± 63.0^a,d	323.7 ± 128.1^a,c	62.2 ± 216.3^a,d	1588.7 ± 697.8^c	-1012.3 ± 274.9^d	373.7 ± 362.1^a,c	4476.1 ± 762.3^b
Renal
Mg ATPase	90.5 ± 12.1^a	631.8 ± 53.0^c	130.5 ± 16.6^a,b	362.2 ± 27.4^d	205.0 ± 10.4^b,e	126.8 ± 23.3^a,b	221.4 ± 28.4^e
Na-K ATPase	258.3 ± 15.3^a	107.9 ± 24.4^b	147.4 ± 31.3^b	103.8 ± 25.7^b	118.8 ± 27.8^b	109.2 ± 32.6^b	171.3 ± 28.8^b
Ca ATPase	131.8 ± 8.8^a,d	57.9 ± 7.6^c,e	124.4 ± 11.0^d	40.9 ± 11.3^e	77.8 ± 6.7^b,c	157.1 ± 11.1^a	93.7 ± 9.5^b
Triglyceride	90.9 ± 15.9^a	117.6 ± 33.4^a	114.8 ± 17.2^a	147.4 ± 35.5^a	97.6 ± 28.1^a	129.4 ± 35.3^a	102.6 ± 34.7^a
Cholesterol	25.7 ± 9.6^a	105.3 ± 18.8^b	120.2 ± 19.9^b	91.1 ± 25.8^a,b	94.7 ± 21.3^b	125.1 ± 26.1^b	113.1 ± 30.9^b
Calcium	108.9 ± 10.7^a	89.1 ± 10.1^b	121.2 ± 11.8^a	132.3 ± 7.6^a	131.5 ± 11.1^a	132.0 ± 9.4^a	119.5 ± 6.1^a
Potassium	15.0 ± 2.5^a	37.9 ± 3.1^c	14.4 ± 4.2^a	49.5 ± 2.3^c,d	83.0 ± 7.6^e	70.1 ± 2.2^b,e	60.0 ± 7.2^b,d
Magnesium	341.4 ± 3.7^a	244.8 ± 5.0^b	189.2 ± 4.9^c	155.7 ± 2.9^d	265.2 ± 5.7^e	80.3 ± 3.1^f	241.6 ± 5.0^b
Chloride	46.0 ± 6.0^a	135.6 ± 8.7^c	38.8 ± 7.6^a	174.4 ± 7.3^d	142.5 ± 8.2^b,c	30.9 ± 1.6^a	161.7 ± 10.0^b,d
Sodium	99.1 ± 3.0^a,c	82.7 ± 4.1^b	92.0 ± 2.7^a,b	82.7 ± 7.1^b	81.0 ± 5.9^b	110.7 ± 3.5^c	80.0 ± 6.1^b
Ascorbic acid	44.8 ± 2.0^a	67.5 ± 2.1^c	69.9 ± 2.3^c	12.8 ± 1.6^d	13.5 ± 1.4^d	6.2 ± 0.3^e	25.2 ± 2.5^b
MDA	109.5 ± 14.3^a,b	109.2 ± 9.2^a,b	114.8 ± 15.6^a,b	132.4 ± 8.7^a,b	113.30 ± 7.0^a,b	96.4 ± 20.8^a	140.9 ± 12.7^b
SOD	213.0 ± 18.7^a,c	122.8 ± 16.2^b	164.7 ± 16.9^b,c	227.7 ± 13.2^a	182.9 ± 11.9^a,c	204.8 ± 30.6^a,c	197.0 ± 27.3^a,c
Catalase	101.7 ± 18.0^a	101.0 ± 16.2^a	58.7 ± 5.7^b	113.0 ± 6.0^a,c	78.0 ± 13.3^a,b	104.9 ± 5.0^a	141.5 ± 13.7^c
Glutathione peroxidise	133.5 ± 2.9^a	104.3 ± 12.9^c,e	61.7 ± 8.0^b,c	86.6 ± 12.6^d	57.8 ± 3.6^b	72.5 ± 5.8^b,d	92.4 ± 4.3^d,e

Open in a new tab

Values are mean ± SEM, n = 5. Values in the same row with different superscript letters differ significantly at P < .05.

MDA = malondialdehyde; SOD = superoxide dismutase.

Discussion

One of the major contributors to doxorubicin toxicity is oxidative stress, which leads to membrane lipid peroxidation, and oxidation and cross-linking of cellular thiols.¹ That the doxorubicin administration produced oxidative stress in this study, is supported by the elevated renal malondialdehyde and lowered renal ascorbic acid levels, as well as the reduced renal activities of catalase, glutathione peroxidase and superoxide dismutase, observed in the Test control group. This result is in consonance with earlier reports.^2,7–9 Pre-treatment with the extracts and metformin attenuated the doxorubicin-induced oxidative stress, by lowering the renal malondialdehyde and raising the ascorbic acid levels, and activities of catalase, glutathione peroxidase and superoxide dismutase. This antioxidant protective effect is in agreement with the reports of the improvement of ocular antioxidant levels in alloxan-induced diabetic rats by T procumbens extract,⁴¹ and improvement of antioxidant levels in the diaphragms of streptozotocin-induced diabetic rats by C odorata extract.⁴² This result supports the suggestion by Lee et al⁶⁸ that significant enhancements of endogenous enzymatic antioxidants by plant extracts might be a good strategy for decreasing oxidative stress in tissues. So, these increases caused by the extracts, signify a consolidation of the endogenous antioxidant status of renal tissues, and their subsequent shielding from free radical damage.⁴¹ The high ascorbic acid content in the renal tissues may be sequel to the high content of ascorbic acid in the leaves.⁵³ The extracts may owe their antioxidant protective effects to the presence in them of any 1 or a combination of 2 or more, of allicin, caffeic acid, ellagic acid, epicatechin, lycopene, naringenin, quercetin and silymarin; whose antioxidant and nephro-protective effects have been variously reported.

In this study, induction of oxidative stress by doxorubicin raised plasma urea and creatinine levels. This is in line with other reports of doxorubicin-induced elevation in plasma creatinine and urea levels.^2,7 Plasma biomarkers such as creatinine and urea concentrations are usually monitored to evaluate glomerular function, because of their inverse relationship with the latter.^69–73 Therefore, the reduction in the plasma creatinine and urea levels, produced by the extracts, is suggestive of their capacity to protect the nephrons from doxorubicin-induced damage,⁸ and thus preserve the functional capacity of the glomerular filtration apparatus. The extracts’ lowering of plasma creatinine, blood urea nitrogen and urea may be due to their content of caffeic and chlorogenic acids, both of which had been reported to decrease plasma levels of kidney markers to near-normal levels.^74,75

In this study, doxorubicin treatment caused significant increase in renal cholesterol and triglycerides. This is in conformity with reports of doxorubicin-induced increases in renal cholesterol and triglycerides levels in both humans and experimental animals.^76,77 However, pre-treatment with the extracts prevented this cholesterol and triglyceride accumulation. This effect may be sequel to the presence in the extracts, of chlorogenic acid, ellagic acid, naringenin and quercetin,^{21,22,23,26,78} which are known to lower adiposity and triglyceride contents,^79–81 and modulate hepatic lipids.^82–85 The renal cholesterol lowering activity of the extracts has serious implications on the integrity and function of the renal cell membranes. This is because studies have shown that the level of cholesterol in membranes correlates inversely with the fluidity of membranes.^86–88 Cholesterol plays a major role in the control of the structure and dynamics of the lipid bilayer (fluidity); and therefore, can modulate the activities of various membrane transporters such as Ca²⁺-ATPase, Mg²⁺-ATPase, Na⁺,K⁺-ATPase and Ca²⁺ channels in various cells.^89–92

In this study, the administration of doxorubicin produced significantly lowered Na⁺,K⁺-ATPase, Mg²⁺-ATPase and Ca²⁺-ATPase activities in the renal tissues. This corroborated earlier report of doxorubicin-induced significant reductions in renal Na⁺,K⁺-ATPase, Ca²⁺-ATPase and Mg²⁺-ATPase activities.^1,11 It however, negates the report by Ma et al,⁹³ of doxorubicin-induced significant activation of Na⁺,K⁺-ATPase activity. Pre-treatment with the extracts raised the renal activities of Na⁺,K⁺-, Mg²⁺- and Ca²⁺-ATPases. The extracts’ ability to increase ATPase activities may be due to the presence of any one or both of ascorbic acid and epicatechin, earlier reported in them. According to Kumar et al⁹⁴ ascorbic acid or epicatechin prevents oxidative stress-induced lowering of Ca²⁺-ATPase and Na⁺,K⁺-ATPase activities.

The extracts may have improved Na⁺,K⁺-ATPase, Ca²⁺-ATPase and Mg²⁺-ATPase activities by preventing doxorubicin-induced lipid peroxidation or oxidative stress and cholesterol loading, thereby preventing the subsequent oxidative modification of the enzymes, as well as the modification of the membrane lipid environment and fluidity of the plasma membrane. They may have accomplished the augmentation of ATPase activities via any one or a combination of 2 or more of the following. Firstly, the direct interaction between the phytoconstituents in the extracts and the enzymes may have resulted in changes in the enzymes’ structure, and consequent changes in its activity, or protection of the enzymes’ sulfhydryl groups,^95,96 from interacting with doxorubicin or its metabolites, or from oxidation and subsequent formation of disulphide bridges. Secondly, by reducing the concentration of free radicals and reactive oxygen species, and consequently, reducing oxidative stress and lipid peroxidation^94,97–101 Thirdly, by the impact of their phytoconstituents in preventing increased lipid order and lowered membrane fluidity;^{90,91,97,101–104} which are products of increased cholesterol content and lipid peroxidation.^86,105 Lastly, by the impact of the phytoconstituents in the extracts, on the lipids of the plasma membrane which in turn may have led to changes in the surrounding lipid environment or protein-lipid interactions.^{90,91,97,101,106–108}

Therefore, the reduction in lipid peroxidation (or oxidative stress) and/or tissue cholesterol, as well as protection of the enzymes’ sulfhydryl groups may be responsible for the extracts ability to increase renal Na⁺,K⁺-ATPase, Ca²⁺-ATPase and Mg²⁺-ATPase activities. The significance of these modulations of renal ATPases cannot be overemphasized, given that Na⁺,K⁺-ATPase is important in controlling the reabsorption of Na⁺ and water in the kidney^109,110; while Ca²⁺-ATPase is involved in renal active Ca²⁺ transport.^111,112

Consequently, the elevated concentrations of renal calcium and sodium, as well as the lowered chloride, magnesium and potassium, induced by doxorubicin in this study, is reflective of compromised membranes of the renal tissues. However, pre-treatment with the extracts prevented the doxorubicin-induced electrolyte imbalance. This ability to modulate renal electrolytes may also be due to the presence of chlorogenic acid, which had been reported to improve mineral pool distribution in plasma, spleen and liver.¹¹³ The reduction of renal cholesterol content may have resulted in the reduction in renal calcium content by the extracts. This is in view of the reports that decrease in cholesterol content of plasma membranes leads to decreased Ca²⁺ influx through the Ca²⁺ channel in plasma membranes, which results in decreases in intracellular calcium, and vice versa.^87,114–116 Reduction in membrane cholesterol has also been reported to stimulate the activities of Ca²⁺-, Mg²⁺- and Na⁺,K⁺-ATPases,^87,117,118 which modulates the transport of calcium, magnesium, potassium and sodium ions across plasma membranes,^90,119–127 and by extension, intracellular electrolyte balance. This suggests that modulation of renal calcium, sodium and magnesium levels by the extracts may have been achieved via an interplay of the modulation of renal cholesterol concentration and Ca²⁺-, Na⁺,K⁺- and Mg²⁺-ATPases.

Therefore, taken together, we can safely posit that the extracts acted by boosting endogenous antioxidant and modifying the micro-viscosity of renal membrane via lowering cholesterol levels, and reducing doxorubicin-induced oxidative stress (lipid peroxidation) and protein sulfhydryl modification; and that the ensuing increased fluidity caused improved Ca²⁺-, Mg²⁺- and Na⁺,K⁺-ATPase activities. The subsequent improvement in ion transport then led to improved electrolyte balance, especially, offsetting doxorubicin-induced calcium overload. This may be the mechanism of nephroprotective activities of the extracts. This therefore, is a suggestion of their prospect as resources for prevention or management of doxorubicin-induced renal toxicity.

Data accessibility statement

All relevant data are within the paper.

Competing interests

The authors have declared that no competing interests exist.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References

[1].Malarkodi DP, Balachandar AV, Varalakshmi P. The influence of lipoic acid on adriamycin induced nephrotoxicity in rats. Mol Cell Biochem. 2003;247:15–22. [DOI] [PubMed] [Google Scholar]
[2].Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006;218:164–171. [DOI] [PubMed] [Google Scholar]
[3].Chen X, Zhang Y, Zhu Z, et al. Protective effect of berberine on doxorubicin–induced acute hepatorenal toxicity in rats. Mol Med Rep. 2016;13:3953–3960. [DOI] [PubMed] [Google Scholar]
[4].Nagai K, Fukuno S, Otani K, et al. Prevention of doxorubicin-induced renal toxicity by theanine in rats. Pharmacology. 2018;101:219–224. [DOI] [PubMed] [Google Scholar]
[5].Ahmed OM, Abdul-Hamid MM, El-Bakry AM, et al. Effects of green tea infusion and epicatechin on doxorubicin-induced renocardiotoxicity in male albino rats. Int J Pharm Sci Res. 2019;10:1000–1014. [Google Scholar]
[6].Sabapathy V, Cheru NT, Corey R, Mohammad S, Sharma R. A novel hybrid cytokine IL233 mediates regeneration following doxorubicin-induced nephrotoxic injury. Sci Rep. 2019;9:3215.doi: 10.1038/s41598-019-39886-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
[7].Öz E, İlhan MN. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol Cell Biochem. 2006;286:11–15. [DOI] [PubMed] [Google Scholar]
[8].Jambhulkar S, Deshireddy S, Jestadi DB, et al. Quercetin attenuating doxorubicin induced hepatic, cardiac and renal toxicity in male albino Wistar rats. Am J Phytomed Clin Ther. 2014;2:985–1004. [Google Scholar]
[9].Mesbah L, Kheira B, Wided K, et al. Polyphenolic fractions of Algerian propolis reverses doxorubicin induced acute renal oxidative stress. Afr J Pharm Pharmacol. 2010;4:712–720. [PubMed] [Google Scholar]
[10].Khan TH, Ganaie MA, Alharthy KM, Madkhali H, Jan BL, Sheikh IA. Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats. Arch Physiol Biochem. 2018;126:300–307. [DOI] [PubMed] [Google Scholar]
[11].Bakker WW, Kalicharan D, Donga J, Hulstaert CE, Hardonk MJ. Decreased ATPase activity in Adriamycin nephrosis is independent of proteinuria. Kidney Int. 1987;31:704–709. [DOI] [PubMed] [Google Scholar]
[12].Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A, Rafieian-Kopaei M. Bright renoprotective properties of metformin beyond blood glucose regulatory effects. Iran J Kidney Dis. 2013;7:423–428. [PubMed] [Google Scholar]
[13].Kobashigawa LC, Xu YC, Padbury JF, Tseng YT, Yano N. Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study. PLoS One. 2014;9:e104888.doi: 10.1371/journal.pone.0104888. [DOI] [PMC free article] [PubMed] [Google Scholar]
[14].Pandey A, Kumar VL. Protective effect of metformin against acute inflammation and oxidative stress in rat. Drug Dev Res. 2016;77:278–284. [DOI] [PubMed] [Google Scholar]
[15].Ommati MM, Mohammadi H, Mousavi K, et al. Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function. Liver Res. 2020; 10.1016/j.livres.2020.12.001. [DOI] [Google Scholar]
[16].Eisenreich A, Leppert U. Update on the protective renal effects of metformin in diabetic nephropathy. Curr Med Chem. 2017;24:3397–3412. [DOI] [PubMed] [Google Scholar]
[17].Ravindran S, Kuruvilla V, Wilbur K, Munusamy S. Nephroprotective effects of metformin in diabetic nephropathy. J Cell Physiol. 2017;232:731–742. [DOI] [PubMed] [Google Scholar]
[18].Rizk FH, El Saadany AA, Dawood L, et al. Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone. J Inflamm Res. 2018;11:421–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
[19].Surai PF. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants. 2015;4:204–247. [DOI] [PMC free article] [PubMed] [Google Scholar]
[20].Ikewuchi JC, Ikewuchi CC, Igboh MN. Chemical profile of Tridax procumbens Linn. Pak J Nutr. 2009;8:548–550. [Google Scholar]
[21].Ikewuchi JC. An aqueous extract of the leaves of Tridax procumbens Linn (Asteraceae) protected against carbon tetrachloride induced liver injury in Wistar rats. Pac J Sci Technol. 2012;13:519–527. [Google Scholar]
[22].Ikewuchi JC, Ikewuchi CC, Enuneku EC, et al. Alteration of blood pressure indices and pulse rates by an aqueous extract of the leaves of Chromolaena odorata (L) King and Robinson (Asteraceae). Pac J Sci Technol. 2012;13:348–358. [Google Scholar]
[23].Ikewuchi JC, Ikewuchi CC, Ifeanacho MO. Analysis of the phytochemical composition of the leaves of Chromolaena odorata King and Robinson by gas chromatography-flame ionization detector. Pac J Sci Technol. 2013;14:360–378. [Google Scholar]
[24].Ikewuchi JC, Ikewuchi CC, Ifeanacho MO. Attenuation of salt-loading induced cardiomegaly and dyslipidemia in Wistar rats by aqueous leaf extract of Chromolaena odorata. Pharmacol Pharm. 2014;5:160–170. doi: 10.4236/pp.2014.52022. [Google Scholar]
[25].Ikewuchi JC, Ikewuchi CC, Ifeanacho MO. An aqueous extract of the leaves of Chromolaena odorata moderated plasma biochemical and hematological indices of sub-chronic salt-loaded rats. Asian J Pharml Res. 2014;4:24–35. [Google Scholar]
[26].Ikewuchi CC, Ikewuchi JC, Ifeanacho MO. Phytochemical composition of Tridax procumbens Linn leaves: Potential as a functional food. Food Nutr Sci. 2015;6:992–1004. [Google Scholar]
[27].Yagmurca M, Erdogan H, Iraz M, et al. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta. 2004;348:27–34. [DOI] [PubMed] [Google Scholar]
[28].Gnanasoundari M, Pari L. Impact of naringenin on oxytetracycline-mediated oxidative damage in kidney of rats. Renal Fail. 2006;28:599–605. [DOI] [PubMed] [Google Scholar]
[29].El-Shitany NA, El-Haggar S, El-Desoky K. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol. 2008;46:2422–2428. [DOI] [PubMed] [Google Scholar]
[30].Renugadevi J, Prabu SM. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology. 2009;256:128–134. [DOI] [PubMed] [Google Scholar]
[31].El-Kashef DH, El-Kenawi AE, Suddek GM, et al. Protective effect of allicin against gentamicin-induced nephrotoxicity in rats. Int Immunopharmacol. 2015;29:679–686. [DOI] [PubMed] [Google Scholar]
[32].Omar WM, Raslan YA, Amany AEA, et al. The ameliorative effect of ellagic acid and rosemarinic acid against cardio-nephrotoxicity induced by doxorubicin in rats. Int J Sci Res Pub. 2016;6:249–256. [Google Scholar]
[33].Ikewuchi JC, Ikewuchi CC. Alteration of plasma lipid profile and atherogenic indices of cholesterol loaded rats by Tridax procumbens Linn: Implications for the management of obesity and cardiovascular diseases. Biokemistri. 2009;21:95–99. [Google Scholar]
[34].Ikewuchi JC, Ikewuchi CC, Onwuka FC. Effect of aqueous extract of Tridax procumbens Linn on plasma electrolytes of salt-loaded rats. Pak J Nutr. 2010;9:103–105. [Google Scholar]
[35].Ikewuchi JC, Ikewuchi CC. Anti-cholesterolemic effect of aqueous extract of the leaves of Chromolaena odorata (L) King and Robinson (Asteraceae): Potential for the reduction of cardiovascular risk. Pac J Sci Technol. 2011;12:385–391. [Google Scholar]
[36].Ikewuchi JC, Onyeike EN, Uwakwe AA, et al. Effect of aqueous extract of the leaves of Tridax procumbens Linn on blood pressure components and pulse rates of sub chronic salt-loaded rats. Pac J Sci Technol. 2011;12:381–389. [Google Scholar]
[37].Ikewuchi JC, Onyeike EN, Uwakwe AA, et al. Weight reducing and hypocholesterolemic effect of aqueous extract of the leaves of Tridax procumbens Linn on sub-chronic salt-loaded rats. Int J Biol Chem Sci. 2011;5:680–687. [Google Scholar]
[38].Ikewuchi JC, Ikewuchi CC. Moderation of haematological indices, plasma electrolytes and markers of hepato-renal function in sub-chronic salt-loaded rats by an aqueous leaf extract of Tridax procumbens Linn (Asteraceae). Pac J Sci Technol. 2013;14:362–369. [Google Scholar]
[39].Ifeanacho MO, Ikewuchi JC, Ikewuchi CC, et al. Prevention of doxorubicin-induced dyslipidaemia, plasma oxidative stress and electrolytes imbalance in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens. Scientific Afr. 2020;11:e00636.doi: 10.1016/j.sciaf.2020.e00636. [Google Scholar]
[40].Ravikumar V, Shivashangari KS, Devaki T. Hepatoprotective activity of Tridax procumbens against d-galactosamine/lipopolysaccharide-induced hepatitis in rats. J Ethnopharmacol. 2005;101:55–60. [DOI] [PubMed] [Google Scholar]
[41].Ikewuchi JC. Alteration of plasma biochemical, haematological and ocular oxidative indices of alloxan induced diabetic rats by aqueous extract of Tridax procumbens Linn (Asteraceae). EXCLI J. 2012;11:291–308. [PMC free article] [PubMed] [Google Scholar]
[42].Onkaramurthy M, Veerapur VP, Thippeswamy BS, et al. Anti-diabetic and anti-cataract effects of Chromolaena odorata Linn., in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2013;145:363–372. [DOI] [PubMed] [Google Scholar]
[43].Palanisamy P, Chandra RM, Jaykar B, et al. Evaluation of hepatoprotective activity of whole plant extract of Chromolaena odorata King and H. Rob in carbon tetra chloride and rifampicin induced rats. IJPTP. 2014;5:1574–1581. [Google Scholar]
[44].Kumar RSAS, Samuel PNKJ, Selvakumar M, et al. Anti-oxidant, anti-diabetic, antimicrobial and hemolytic activity of Tridax procumbens. J Chem Pharm Res. 2016;8:808–812. [Google Scholar]
[45].Vishnu PP, Srinivasa RA. Evaluation of anticancer activity of Tridax procumbens leaf extracts on A549 and Hep G2 cell lines. Asian J Pharmaceut Clin Res. 2015;8:129–132. [Google Scholar]
[46].Adedapo AA, Oyagbemi AA, Fagbohun OA, et al. Evaluation of the anticancer properties of the methanol leaf extract of Chromolaena odorata on HT-29 cell line. J Pharmacogn Phytochem. 2016;5:52–57. [Google Scholar]
[47].Sujitha R, Sharmila R. Phytochemical analysis and in vitro anticancer activity of Tridax procumbens Linn. World J Pharmaceut Res. 2018;7:867–878. [Google Scholar]
[48].Bhargava D, Mondal CK, Shivapuri JN, et al. Antioxidant properties of the leaves of Chromolaena odorata Linn. J Institute Med. 2013;35:53–56. [Google Scholar]
[49].Andriana Y, Xuan TD, Quy TN, Minh TN, Van TM, Viet TD. Antihyperuricemia, antioxidant, and antibacterial activities of Tridax procumbens L. Foods. 2019;8:21.doi: 10.3390/foods8010021. [DOI] [PMC free article] [PubMed] [Google Scholar]
[50].Putri DA, Fatmawati S. A new flavanone as a potent antioxidant isolated from Chromolaena odorata L. leaves. Evid Based Complement Alternat Med. 2019;2019:1453612.doi: 10.1155/2019/1453612. [DOI] [PMC free article] [PubMed] [Google Scholar]
[51].Cui HX, Zhang LS, Yan HG, et al. Constituents of flavonoids from Tridax procumbens L. and antioxidant activity. Phcog Mag. 2020;16:201–205. [Google Scholar]
[52].Syed A, Benit N, Alyousef AA, Alqasim A, Arshad M. In-vitro antibacterial, antioxidant potentials and cytotoxic activity of the leaves of Tridax procumbens. Saudi J Biol Sci. 2020;27:757–761. [DOI] [PMC free article] [PubMed] [Google Scholar]
[53].Ikewuchi CC, Ikewuchi JC. Comparative study on the vitamin composition of some common Nigerian medicinal plants. Pac J Sci Technol. 2009;10 1:367–371. [Google Scholar]
[54].National Research Council. Guide for the Care and Use of Laboratory Animals. 8th edWashington, DC: The National Academies Press; 2011. [Google Scholar]
[55].Protein quality evaluation: Report of Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper 51. Rome: Food and Agriculture Organization of the United Nations; 1991. [Google Scholar]
[56].Song S, Chu L, Liang H, et al. Protective effects of dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1/FOXO1/NF-κb signal. Front Pharmacol. 2019;10:1030.doi: 10.3389/fphar.2019.01030. [DOI] [PMC free article] [PubMed] [Google Scholar]
[57].Zilinyi R, Czompa A, Czegledi A, et al. The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy. Molecules. 2018;23:1184.doi: 10.3390/molecules23051184. [DOI] [PMC free article] [PubMed] [Google Scholar]
[58].Ifeanacho MO, Ikewuchi CC, Ikewuchi JC. Anti-diabetic effect of a flavonoid and sitosterol—rich aqueous extract of Pleurotus tuberregium sclerotia in alloxan-induced diabetic rabbits. Endocr Metab Immune Disord Drug Targets. 2019;19:1148–1156. [DOI] [PubMed] [Google Scholar]
[59].Gutteridge J, Wilkins S. Copper-dependent hydroxyl radical damage to ascorbic acid. FEBS Lett. 1982;137:327–330. [DOI] [PubMed] [Google Scholar]
[60].Ikewuchi JC, Ikewuchi CC. Iodometric determination of the ascorbic acid (vitamin C) content of some fruits consumed in a university community in Nigeria. Global J Pure Applied Sci. 2011;17:47–49. [Google Scholar]
[61].Beers RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195:133–140. [PubMed] [Google Scholar]
[62].Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a single assay for superoxide dismutase. J Biol Chem. 1972;247:3170–3175. [PubMed] [Google Scholar]
[63].Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–590. [DOI] [PubMed] [Google Scholar]
[64].Hesketh JE, Loudon JB, Reading HW, et al. The effect of lithium treatment on erythrocyte membrane ATPase activities and erythrocyte ion content. Br J Clin Pharmacol. 1978;5:323–329. [Google Scholar]
[65].Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375–400. [Google Scholar]
[66].Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]
[67].Manoeuvrier G, Bach-Ngohou K, Batard E, Masson D, Trewick D. Diagnostic performance of serum blood urea nitrogen to creatinine ratio for distinguishing prerenal from intrinsic acute kidney injury in the emergency department. BMC Nephrol. 2017;18:173.doi: 10.1186/s12882-017-0591-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
[68].Lee CH, Park JH, Cho JH, et al. Effect of Oenanthe javanica extract on antioxidant enzyme in the rat liver. Chin Med J. 2015;128:1649–1654. [DOI] [PMC free article] [PubMed] [Google Scholar]
[69].Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am. 2005;89 3:457–473. [DOI] [PubMed] [Google Scholar]
[70].Crook MA. Clinical Biochemistry and Metabolic Medicine. 8th edLondon: Hodder and Stoughton Ltd; 2012. [Google Scholar]
[71].Lamb EJ, Price CP. Burtis CA, Bruns DE. Kidney function tests—creatinine, urea, and uric acid. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. 7th edSt. Louis, Missouri: Saunders; 2015;364–375. [Google Scholar]
[72].Meisenberg G, Simmons WH. Principles of Medical Biochemistry. 4th edPhiladelphia, PA: Elsevier, Inc.; 2017. [Google Scholar]
[73].Lieberman M, Peet A. Marks’ Basic Medical Biochemistry—A Clinical Approach. 5th edPhiladelphia, PA: Wolters Kluwer; 2018. [Google Scholar]
[74].Pari L, Karthi Kesan K. Protective role of caffeic acid against alcohol-induced biochemical changes in rats. Fundam Clin Pharmacol. 2007;21:355–361. [DOI] [PubMed] [Google Scholar]
[75].Lou J, Gu X, Xing Y, et al. Chlorogenic acid slows down proteinuria and renal fibrosis in 5/6-nephrectomized rats by anti-oxidation and inhibiting accumulation of extracellular matrix. Int J Clin Exp Med. 2016;9:15719–15727. [Google Scholar]
[76].Subashini R, Ragavendran B, Gnanapragasam A, et al. Biochemical study on the protective potential of Nardostachys jatamansi extract on lipid profile and lipid metabolizing enzymes in doxorubicin intoxicated rats. Pharmazie. 2007;62:382–387. [PubMed] [Google Scholar]
[77].Sharma M, Tuaine J, McLaren B, et al. Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells. PLoS One. 2016;11:e0148049.doi: 10.1371/journal.pone.0148049. [DOI] [PMC free article] [PubMed] [Google Scholar]
[78].Pitakpawasutthi Y, Thitikornpong W, Palanuvej C, et al. Chlorogenic acid content, essential oil compositions, and in vitro antioxidant activities of Chromolaena odorata leaves. J Adv Pharm Technol Res. 2016;7:37–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
[79].Cho KW, Kim YO, Andrade JE, Burgess JR, Kim YC. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor alpha protein expression and decreases plasma triglyceride and adiposity in rats. Eur J Nutr. 2011;50:81–88. [DOI] [PubMed] [Google Scholar]
[80].Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 2014;5:404–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
[81].Okla M, Kang I, Kim DM, et al. Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms. J Nutr Biochem. 2015;26:82–90. [DOI] [PubMed] [Google Scholar]
[82].Padma VV, Lalitha G, Shirony NP, et al. Effect of quercetin against lindane induced alterations in the serum and hepatic tissue lipids in Wistar rats. Asian Pac J Trop Biomed. 2012;2:910–915. [DOI] [PMC free article] [PubMed] [Google Scholar]
[83].Wan CW, Wong CN, Pin WK, et al. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemicrats induced with a high-cholesterol diet. Phytother Res. 2013;27:545–551. [DOI] [PubMed] [Google Scholar]
[84].Snyder SM, Zhao B, Luo T, et al. Consumption of quercetin and quercetin-containing apple and cherry extracts affects blood glucose concentration, hepatic metabolism, and gene expression patterns in obese C57BL/6J high fat-fed mice. J Nutr. 2016;146:1001–1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
[85].Leng L, Xiao Y, Mo Z, et al. Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells. BMC Complement Altern Med. 2018;18:122.doi: 10.1186/s12906-018-2189-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
[86].Le Grimellec C, Friedlander G, El Yandouzi EH, Zlatkine P, Giocondi MC. Membrane fluidity and transport properties in epithelia. Kidney Int. 1992;42:825–836. [DOI] [PubMed] [Google Scholar]
[87].Bastiaanse EML, Höld KM, Van der Laarse A. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res. 1997;33:272–283. [DOI] [PubMed] [Google Scholar]
[88].Yeagle PL. Yeagle PL. The roles of cholesterol in the biology of cells. The Structure of Biological Membranes. 3rd edBoca Raton: CRC Press; 2012;119–129. [Google Scholar]
[89].Balut C, Steels P, Radu M, Ameloot M, Driessche WV, Jans D. Membrane cholesterol extraction decreases Na⁺ transport in A6 renal epithelia. Am J Physiol Cell Physiol. 2006;290:C87–C94. [DOI] [PubMed] [Google Scholar]
[90].Grebowski J, Krokosz A, Puchala M. Membrane fluidity and activity of ATPases in human erythrocytes under the influence of polyhydroxylated fullerene. Biochim Biophys Acta. 2013;1828:241–248. [DOI] [PubMed] [Google Scholar]
[91].Krokosz A, Grebowski J. Chakraborti S, Dhalla NS. Activity of membrane ATPases in human erythrocytes under the influence of highly hydroxylated fullerenol. Regulation of Membrane Na⁺,K⁺-ATPase, Advances in Biochemistry in Health and Disease 15. Switzerland: Springer International Publishing; 2016;159–172. [Google Scholar]
[92].Garcia A, Lev B, Hossain KR, et al. Cholesterol depletion inhibits Na⁺,K⁺-ATPase activity in a near-native membrane environment. J Biol Chem. 2019;294:5956–5969. [DOI] [PMC free article] [PubMed] [Google Scholar]
[93].Ma S, Jia R, Li D, et al. Targeting cellular metabolism chemosensitizes the doxorubicin-resistant human breast adenocarcinoma cells. BioMed Res Int. 2015;2015:453986.doi: 10.1155/2015/453986. [DOI] [PMC free article] [PubMed] [Google Scholar]
[94].Kumar N, Kant R, Maurya PK, et al. Concentration dependent effect of (−)-epicatechin on Na⁺,K⁺-ATPase and Ca²⁺-ATPase inhibition induced by free radicals in hypertensive patients: Comparison with L-ascorbic acid. Phytother Res. 2002;26:1644–1647. [DOI] [PubMed] [Google Scholar]
[95].Nicotera P, Moore M, Mirabelli F, et al. Inhibition of hepatocyte plasma membrane Ca²⁺-ATPase activity by menadione metabolism and its restoration by thiols. FEBS Lett. 1985;181:149–153. [DOI] [PubMed] [Google Scholar]
[96].Hanna AD, Lam A, Tham S, Dulhunty AF, Beard NA. Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Mol Pharmacol. 2014;86:438–449. [DOI] [PMC free article] [PubMed] [Google Scholar]
[97].Paterson CA, Zeng J, Husseini Z, et al. Calcium ATPase activity and membrane structure in clear and cataractous human lenses. Curr Eye Res. 1997;16:333–338. [DOI] [PubMed] [Google Scholar]
[98].Torliñska T, Grochowalska A. Age-related changes of Na⁺,K⁺-ATPase, Ca²⁺-ATPase and Mg²⁺-ATPase activities in rat brain synaptosomes. J Physiol Pharmacol. 2004;55:457–465. [PubMed] [Google Scholar]
[99].Patel V, Upaganlawar A, Zalawadia R, et al. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644:160–168. [DOI] [PubMed] [Google Scholar]
[100].Simão F, Matté A, Matté C, et al. Resveratrol prevents oxidative stress and inhibition of Na⁺,K⁺-ATPase activity induced by transient global cerebral ischemia in rats. J Nutr Biochem. 2011;22:921–928. [DOI] [PubMed] [Google Scholar]
[101].Conrard L, Tyteca D. Regulation of membrane calcium transport proteins by the surrounding lipid environment. Biomolecules. 2019;9:513.doi: 10.3390/biom9100513. [DOI] [PMC free article] [PubMed] [Google Scholar]
[102].Sutherland E, Dixon BS, Leffert HL, et al. Biochemical localization of hepatic surface membrane Na⁺,K⁺-ATPase activity depends on membrane lipid fluidity. Proc Natl Acad Sci USA. 1988;85:8673–8677. [DOI] [PMC free article] [PubMed] [Google Scholar]
[103].Delamere NA, Paterson CA, Borchman D, et al. Calcium transport, Ca²⁺-ATPase, and lipid order in rabbit ocular lens membranes. Am J Physiol. 1991;260 (Pt 1):C731–C737. [DOI] [PubMed] [Google Scholar]
[104].Mozanti L, Rabini RA, Biagini G, et al. Changes in membrane fluidity and Na⁺,K⁺-ATPase activity during human trophoblast cell culture. Eur J Biochem. 1992;206:881–885. [DOI] [PubMed] [Google Scholar]
[105].Wong-Ekkabut J, Xu Z, Triampo W, Tang IM, Tieleman DP, Monticelli L. Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys J. 2007;93:4225–4236. [DOI] [PMC free article] [PubMed] [Google Scholar]
[106].Cocucci M, Ballarin-Denti A. Effect of polar lipids on ATPase activity of membrane preparations from germinating radish seeds. Plant Physiol. 1981;68:377–381. [DOI] [PMC free article] [PubMed] [Google Scholar]
[107].Navarro J, Toivio-Kinnucan M, Racker E. Effect of lipid composition on the calcium/adenosine 5’-triphosphate coupling ratio of the Ca²⁺-ATPase of sarcoplasmic reticulum. Biochemistry. 1984;23:130–135. [DOI] [PubMed] [Google Scholar]
[108].Urbatsch IL, Senior AE. Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein. Arch Biochem Biophys. 1995;316:135–140. [DOI] [PubMed] [Google Scholar]
[109].Glynn IM. Martonosi A. The Na, K-transporting adenosine triphosphatase. The Enzymes of Biological Membranes. 2nd edNew York, NY: Plenum; 1993;35–114. [Google Scholar]
[110].Huang B, Blanco G, Mercer RW, et al. Human corneal endothelial cell expression of Na⁺,K⁺-adenosine triphosphatase isoforms. Arch Ophthalmol. 2003;121:840–845. [DOI] [PubMed] [Google Scholar]
[111].Alexander RT, Beggs MR, Zamani R, et al. Ultrastructural and immunohistochemical localization of plasma membrane Ca²⁺-ATPase 4 in Ca²⁺-transporting epithelia. Am J Physiol Renal Physiol. 2015;309:F604–F616. [DOI] [PubMed] [Google Scholar]
[112].Stafford N, Wilson C, Oceandy D, et al. The plasma membrane calcium ATPases and their role as major new players in human disease. Physiol Rev. 2017;97:1089–1125. [DOI] [PubMed] [Google Scholar]
[113].Rodriguez de Sotillo DV, Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem. 2002;13:717–726. [DOI] [PubMed] [Google Scholar]
[114].Bialecki RA, Tulenko TN. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am J Physiol. 1989;257 (Pt 1):C306–C314. [DOI] [PubMed] [Google Scholar]
[115].Tulenko TN, Bialecki R, Gleason M. Colatsky T, et al. Ion channels, membrane lipids and cholesterol: a role for membrane lipid domains in arterial function. Potassium Channels: Basic Function and Therapeutic Aspects. New York: Alan R Liss; 1990;187–203. [PubMed] [Google Scholar]
[116].Gleason MM, Medow MS, Tulenko TN. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res. 1991;69:216–227. [DOI] [PubMed] [Google Scholar]
[117].Ortega A, Mas-Oliva J. Cholesterol effect on enzyme activity of the sarcolemmal Ca²⁺,Mg²⁺-ATPase from cardiac muscle. Biochim Biophys Acta. 1984;773:231–236. [DOI] [PubMed] [Google Scholar]
[118].Mas-Oliva J, Delgado-Coello B. Protein stability and the evolution of the cell membrane. Comp Biochem Physiol C Toxicol Pharmacol. 2007;146:207–213. [DOI] [PubMed] [Google Scholar]
[119].Doneen BA. High affinity calcium/magnesium ATPase in kidney of euryhaline Gillichthys mirabilis: kinetics, subcellular distribution and effect of salinity. Comp Biochem Physiol. 1993;106B:719–728. [Google Scholar]
[120].Strehler EE, Caride AJ, Filoteo AG, et al. Plasma membrane Ca²⁺ATPases as dynamic regulators of cellular calcium handling. Ann N Y Acad Sci. 2007;1099:226–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
[121].Di Leva F, Domi T, Fedrizzi L, Lim D, Carafoli E. The plasma membrane Ca²⁺ ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys. 2008;476:65–74. [DOI] [PubMed] [Google Scholar]
[122].Vasic VM, Colovic BM, Krstic DZ. Mechanism of Na⁺/K⁺-ATPase and Mg²⁺-ATPase inhibition by metal ions and complexes. Hem Ind. 2009;63:499–509. [Google Scholar]
[123].Brini M, Carafoli E. The plasma membrane Ca²⁺ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol. 2011;3:a004168.doi: 10.1101/cshperspect.a004168. [DOI] [PMC free article] [PubMed] [Google Scholar]
[124].Strehler EE. Plasma membrane calcium ATPases as novel candidates for therapeutic agent development. J Pharm Pharm Sci. 2013;16:190–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
[125].Penniston JT, Padanyi R, Paszty K, et al. Apart from its known function, the plasma membrane Ca²⁺ ATPase can regulate Ca²⁺ signaling by controlling phosphatidylinositol 4,5-bisphosphate levels. J Cell Sci. 2014;127:72–84. [DOI] [PubMed] [Google Scholar]
[126].Álvarez JAL, Murillo TCL, Nestor CAV. Najman S, et al. Epithelial Na⁺,K⁺-ATPase—a sticky pump. Cell biology—New Insights. Croatia: IntechOpen; 2016;29–57. [Google Scholar]
[127].Obradovic M, Stanimirovic J, Panic A. Choi S, et al. Na+/K+-ATPase. Encyclopedia of Signaling Molecules. Switzerland: Springer; 2018;3338–3343. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.

[R1] [1].Malarkodi DP, Balachandar AV, Varalakshmi P. The influence of lipoic acid on adriamycin induced nephrotoxicity in rats. Mol Cell Biochem. 2003;247:15–22. [DOI] [PubMed] [Google Scholar]

[R2] [2].Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006;218:164–171. [DOI] [PubMed] [Google Scholar]

[R3] [3].Chen X, Zhang Y, Zhu Z, et al. Protective effect of berberine on doxorubicin–induced acute hepatorenal toxicity in rats. Mol Med Rep. 2016;13:3953–3960. [DOI] [PubMed] [Google Scholar]

[R4] [4].Nagai K, Fukuno S, Otani K, et al. Prevention of doxorubicin-induced renal toxicity by theanine in rats. Pharmacology. 2018;101:219–224. [DOI] [PubMed] [Google Scholar]

[R5] [5].Ahmed OM, Abdul-Hamid MM, El-Bakry AM, et al. Effects of green tea infusion and epicatechin on doxorubicin-induced renocardiotoxicity in male albino rats. Int J Pharm Sci Res. 2019;10:1000–1014. [Google Scholar]

[R6] [6].Sabapathy V, Cheru NT, Corey R, Mohammad S, Sharma R. A novel hybrid cytokine IL233 mediates regeneration following doxorubicin-induced nephrotoxic injury. Sci Rep. 2019;9:3215.doi: 10.1038/s41598-019-39886-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R7] [7].Öz E, İlhan MN. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol Cell Biochem. 2006;286:11–15. [DOI] [PubMed] [Google Scholar]

[R8] [8].Jambhulkar S, Deshireddy S, Jestadi DB, et al. Quercetin attenuating doxorubicin induced hepatic, cardiac and renal toxicity in male albino Wistar rats. Am J Phytomed Clin Ther. 2014;2:985–1004. [Google Scholar]

[R9] [9].Mesbah L, Kheira B, Wided K, et al. Polyphenolic fractions of Algerian propolis reverses doxorubicin induced acute renal oxidative stress. Afr J Pharm Pharmacol. 2010;4:712–720. [PubMed] [Google Scholar]

[R10] [10].Khan TH, Ganaie MA, Alharthy KM, Madkhali H, Jan BL, Sheikh IA. Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats. Arch Physiol Biochem. 2018;126:300–307. [DOI] [PubMed] [Google Scholar]

[R11] [11].Bakker WW, Kalicharan D, Donga J, Hulstaert CE, Hardonk MJ. Decreased ATPase activity in Adriamycin nephrosis is independent of proteinuria. Kidney Int. 1987;31:704–709. [DOI] [PubMed] [Google Scholar]

[R12] [12].Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A, Rafieian-Kopaei M. Bright renoprotective properties of metformin beyond blood glucose regulatory effects. Iran J Kidney Dis. 2013;7:423–428. [PubMed] [Google Scholar]

[R13] [13].Kobashigawa LC, Xu YC, Padbury JF, Tseng YT, Yano N. Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study. PLoS One. 2014;9:e104888.doi: 10.1371/journal.pone.0104888. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R14] [14].Pandey A, Kumar VL. Protective effect of metformin against acute inflammation and oxidative stress in rat. Drug Dev Res. 2016;77:278–284. [DOI] [PubMed] [Google Scholar]

[R15] [15].Ommati MM, Mohammadi H, Mousavi K, et al. Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function. Liver Res. 2020; 10.1016/j.livres.2020.12.001. [DOI] [Google Scholar]

[R16] [16].Eisenreich A, Leppert U. Update on the protective renal effects of metformin in diabetic nephropathy. Curr Med Chem. 2017;24:3397–3412. [DOI] [PubMed] [Google Scholar]

[R17] [17].Ravindran S, Kuruvilla V, Wilbur K, Munusamy S. Nephroprotective effects of metformin in diabetic nephropathy. J Cell Physiol. 2017;232:731–742. [DOI] [PubMed] [Google Scholar]

[R18] [18].Rizk FH, El Saadany AA, Dawood L, et al. Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone. J Inflamm Res. 2018;11:421–429. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R19] [19].Surai PF. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants. 2015;4:204–247. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R20] [20].Ikewuchi JC, Ikewuchi CC, Igboh MN. Chemical profile of Tridax procumbens Linn. Pak J Nutr. 2009;8:548–550. [Google Scholar]

[R21] [21].Ikewuchi JC. An aqueous extract of the leaves of Tridax procumbens Linn (Asteraceae) protected against carbon tetrachloride induced liver injury in Wistar rats. Pac J Sci Technol. 2012;13:519–527. [Google Scholar]

[R22] [22].Ikewuchi JC, Ikewuchi CC, Enuneku EC, et al. Alteration of blood pressure indices and pulse rates by an aqueous extract of the leaves of Chromolaena odorata (L) King and Robinson (Asteraceae). Pac J Sci Technol. 2012;13:348–358. [Google Scholar]

[R23] [23].Ikewuchi JC, Ikewuchi CC, Ifeanacho MO. Analysis of the phytochemical composition of the leaves of Chromolaena odorata King and Robinson by gas chromatography-flame ionization detector. Pac J Sci Technol. 2013;14:360–378. [Google Scholar]

[R24] [24].Ikewuchi JC, Ikewuchi CC, Ifeanacho MO. Attenuation of salt-loading induced cardiomegaly and dyslipidemia in Wistar rats by aqueous leaf extract of Chromolaena odorata. Pharmacol Pharm. 2014;5:160–170. doi: 10.4236/pp.2014.52022. [Google Scholar]

[R25] [25].Ikewuchi JC, Ikewuchi CC, Ifeanacho MO. An aqueous extract of the leaves of Chromolaena odorata moderated plasma biochemical and hematological indices of sub-chronic salt-loaded rats. Asian J Pharml Res. 2014;4:24–35. [Google Scholar]

[R26] [26].Ikewuchi CC, Ikewuchi JC, Ifeanacho MO. Phytochemical composition of Tridax procumbens Linn leaves: Potential as a functional food. Food Nutr Sci. 2015;6:992–1004. [Google Scholar]

[R27] [27].Yagmurca M, Erdogan H, Iraz M, et al. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta. 2004;348:27–34. [DOI] [PubMed] [Google Scholar]

[R28] [28].Gnanasoundari M, Pari L. Impact of naringenin on oxytetracycline-mediated oxidative damage in kidney of rats. Renal Fail. 2006;28:599–605. [DOI] [PubMed] [Google Scholar]

[R29] [29].El-Shitany NA, El-Haggar S, El-Desoky K. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol. 2008;46:2422–2428. [DOI] [PubMed] [Google Scholar]

[R30] [30].Renugadevi J, Prabu SM. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology. 2009;256:128–134. [DOI] [PubMed] [Google Scholar]

[R31] [31].El-Kashef DH, El-Kenawi AE, Suddek GM, et al. Protective effect of allicin against gentamicin-induced nephrotoxicity in rats. Int Immunopharmacol. 2015;29:679–686. [DOI] [PubMed] [Google Scholar]

[R32] [32].Omar WM, Raslan YA, Amany AEA, et al. The ameliorative effect of ellagic acid and rosemarinic acid against cardio-nephrotoxicity induced by doxorubicin in rats. Int J Sci Res Pub. 2016;6:249–256. [Google Scholar]

[R33] [33].Ikewuchi JC, Ikewuchi CC. Alteration of plasma lipid profile and atherogenic indices of cholesterol loaded rats by Tridax procumbens Linn: Implications for the management of obesity and cardiovascular diseases. Biokemistri. 2009;21:95–99. [Google Scholar]

[R34] [34].Ikewuchi JC, Ikewuchi CC, Onwuka FC. Effect of aqueous extract of Tridax procumbens Linn on plasma electrolytes of salt-loaded rats. Pak J Nutr. 2010;9:103–105. [Google Scholar]

[R35] [35].Ikewuchi JC, Ikewuchi CC. Anti-cholesterolemic effect of aqueous extract of the leaves of Chromolaena odorata (L) King and Robinson (Asteraceae): Potential for the reduction of cardiovascular risk. Pac J Sci Technol. 2011;12:385–391. [Google Scholar]

[R36] [36].Ikewuchi JC, Onyeike EN, Uwakwe AA, et al. Effect of aqueous extract of the leaves of Tridax procumbens Linn on blood pressure components and pulse rates of sub chronic salt-loaded rats. Pac J Sci Technol. 2011;12:381–389. [Google Scholar]

[R37] [37].Ikewuchi JC, Onyeike EN, Uwakwe AA, et al. Weight reducing and hypocholesterolemic effect of aqueous extract of the leaves of Tridax procumbens Linn on sub-chronic salt-loaded rats. Int J Biol Chem Sci. 2011;5:680–687. [Google Scholar]

[R38] [38].Ikewuchi JC, Ikewuchi CC. Moderation of haematological indices, plasma electrolytes and markers of hepato-renal function in sub-chronic salt-loaded rats by an aqueous leaf extract of Tridax procumbens Linn (Asteraceae). Pac J Sci Technol. 2013;14:362–369. [Google Scholar]

[R39] [39].Ifeanacho MO, Ikewuchi JC, Ikewuchi CC, et al. Prevention of doxorubicin-induced dyslipidaemia, plasma oxidative stress and electrolytes imbalance in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens. Scientific Afr. 2020;11:e00636.doi: 10.1016/j.sciaf.2020.e00636. [Google Scholar]

[R40] [40].Ravikumar V, Shivashangari KS, Devaki T. Hepatoprotective activity of Tridax procumbens against d-galactosamine/lipopolysaccharide-induced hepatitis in rats. J Ethnopharmacol. 2005;101:55–60. [DOI] [PubMed] [Google Scholar]

[R41] [41].Ikewuchi JC. Alteration of plasma biochemical, haematological and ocular oxidative indices of alloxan induced diabetic rats by aqueous extract of Tridax procumbens Linn (Asteraceae). EXCLI J. 2012;11:291–308. [PMC free article] [PubMed] [Google Scholar]

[R42] [42].Onkaramurthy M, Veerapur VP, Thippeswamy BS, et al. Anti-diabetic and anti-cataract effects of Chromolaena odorata Linn., in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2013;145:363–372. [DOI] [PubMed] [Google Scholar]

[R43] [43].Palanisamy P, Chandra RM, Jaykar B, et al. Evaluation of hepatoprotective activity of whole plant extract of Chromolaena odorata King and H. Rob in carbon tetra chloride and rifampicin induced rats. IJPTP. 2014;5:1574–1581. [Google Scholar]

[R44] [44].Kumar RSAS, Samuel PNKJ, Selvakumar M, et al. Anti-oxidant, anti-diabetic, antimicrobial and hemolytic activity of Tridax procumbens. J Chem Pharm Res. 2016;8:808–812. [Google Scholar]

[R45] [45].Vishnu PP, Srinivasa RA. Evaluation of anticancer activity of Tridax procumbens leaf extracts on A549 and Hep G2 cell lines. Asian J Pharmaceut Clin Res. 2015;8:129–132. [Google Scholar]

[R46] [46].Adedapo AA, Oyagbemi AA, Fagbohun OA, et al. Evaluation of the anticancer properties of the methanol leaf extract of Chromolaena odorata on HT-29 cell line. J Pharmacogn Phytochem. 2016;5:52–57. [Google Scholar]

[R47] [47].Sujitha R, Sharmila R. Phytochemical analysis and in vitro anticancer activity of Tridax procumbens Linn. World J Pharmaceut Res. 2018;7:867–878. [Google Scholar]

[R48] [48].Bhargava D, Mondal CK, Shivapuri JN, et al. Antioxidant properties of the leaves of Chromolaena odorata Linn. J Institute Med. 2013;35:53–56. [Google Scholar]

[R49] [49].Andriana Y, Xuan TD, Quy TN, Minh TN, Van TM, Viet TD. Antihyperuricemia, antioxidant, and antibacterial activities of Tridax procumbens L. Foods. 2019;8:21.doi: 10.3390/foods8010021. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R50] [50].Putri DA, Fatmawati S. A new flavanone as a potent antioxidant isolated from Chromolaena odorata L. leaves. Evid Based Complement Alternat Med. 2019;2019:1453612.doi: 10.1155/2019/1453612. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R51] [51].Cui HX, Zhang LS, Yan HG, et al. Constituents of flavonoids from Tridax procumbens L. and antioxidant activity. Phcog Mag. 2020;16:201–205. [Google Scholar]

[R52] [52].Syed A, Benit N, Alyousef AA, Alqasim A, Arshad M. In-vitro antibacterial, antioxidant potentials and cytotoxic activity of the leaves of Tridax procumbens. Saudi J Biol Sci. 2020;27:757–761. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R53] [53].Ikewuchi CC, Ikewuchi JC. Comparative study on the vitamin composition of some common Nigerian medicinal plants. Pac J Sci Technol. 2009;10 1:367–371. [Google Scholar]

[R54] [54].National Research Council. Guide for the Care and Use of Laboratory Animals. 8th edWashington, DC: The National Academies Press; 2011. [Google Scholar]

[R55] [55].Protein quality evaluation: Report of Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper 51. Rome: Food and Agriculture Organization of the United Nations; 1991. [Google Scholar]

[R56] [56].Song S, Chu L, Liang H, et al. Protective effects of dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1/FOXO1/NF-κb signal. Front Pharmacol. 2019;10:1030.doi: 10.3389/fphar.2019.01030. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R57] [57].Zilinyi R, Czompa A, Czegledi A, et al. The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy. Molecules. 2018;23:1184.doi: 10.3390/molecules23051184. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R58] [58].Ifeanacho MO, Ikewuchi CC, Ikewuchi JC. Anti-diabetic effect of a flavonoid and sitosterol—rich aqueous extract of Pleurotus tuberregium sclerotia in alloxan-induced diabetic rabbits. Endocr Metab Immune Disord Drug Targets. 2019;19:1148–1156. [DOI] [PubMed] [Google Scholar]

[R59] [59].Gutteridge J, Wilkins S. Copper-dependent hydroxyl radical damage to ascorbic acid. FEBS Lett. 1982;137:327–330. [DOI] [PubMed] [Google Scholar]

[R60] [60].Ikewuchi JC, Ikewuchi CC. Iodometric determination of the ascorbic acid (vitamin C) content of some fruits consumed in a university community in Nigeria. Global J Pure Applied Sci. 2011;17:47–49. [Google Scholar]

[R61] [61].Beers RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195:133–140. [PubMed] [Google Scholar]

[R62] [62].Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a single assay for superoxide dismutase. J Biol Chem. 1972;247:3170–3175. [PubMed] [Google Scholar]

[R63] [63].Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–590. [DOI] [PubMed] [Google Scholar]

[R64] [64].Hesketh JE, Loudon JB, Reading HW, et al. The effect of lithium treatment on erythrocyte membrane ATPase activities and erythrocyte ion content. Br J Clin Pharmacol. 1978;5:323–329. [Google Scholar]

[R65] [65].Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375–400. [Google Scholar]

[R66] [66].Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]

[R67] [67].Manoeuvrier G, Bach-Ngohou K, Batard E, Masson D, Trewick D. Diagnostic performance of serum blood urea nitrogen to creatinine ratio for distinguishing prerenal from intrinsic acute kidney injury in the emergency department. BMC Nephrol. 2017;18:173.doi: 10.1186/s12882-017-0591-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R68] [68].Lee CH, Park JH, Cho JH, et al. Effect of Oenanthe javanica extract on antioxidant enzyme in the rat liver. Chin Med J. 2015;128:1649–1654. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R69] [69].Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am. 2005;89 3:457–473. [DOI] [PubMed] [Google Scholar]

[R70] [70].Crook MA. Clinical Biochemistry and Metabolic Medicine. 8th edLondon: Hodder and Stoughton Ltd; 2012. [Google Scholar]

[R71] [71].Lamb EJ, Price CP. Burtis CA, Bruns DE. Kidney function tests—creatinine, urea, and uric acid. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. 7th edSt. Louis, Missouri: Saunders; 2015;364–375. [Google Scholar]

[R72] [72].Meisenberg G, Simmons WH. Principles of Medical Biochemistry. 4th edPhiladelphia, PA: Elsevier, Inc.; 2017. [Google Scholar]

[R73] [73].Lieberman M, Peet A. Marks’ Basic Medical Biochemistry—A Clinical Approach. 5th edPhiladelphia, PA: Wolters Kluwer; 2018. [Google Scholar]

[R74] [74].Pari L, Karthi Kesan K. Protective role of caffeic acid against alcohol-induced biochemical changes in rats. Fundam Clin Pharmacol. 2007;21:355–361. [DOI] [PubMed] [Google Scholar]

[R75] [75].Lou J, Gu X, Xing Y, et al. Chlorogenic acid slows down proteinuria and renal fibrosis in 5/6-nephrectomized rats by anti-oxidation and inhibiting accumulation of extracellular matrix. Int J Clin Exp Med. 2016;9:15719–15727. [Google Scholar]

[R76] [76].Subashini R, Ragavendran B, Gnanapragasam A, et al. Biochemical study on the protective potential of Nardostachys jatamansi extract on lipid profile and lipid metabolizing enzymes in doxorubicin intoxicated rats. Pharmazie. 2007;62:382–387. [PubMed] [Google Scholar]

[R77] [77].Sharma M, Tuaine J, McLaren B, et al. Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells. PLoS One. 2016;11:e0148049.doi: 10.1371/journal.pone.0148049. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R78] [78].Pitakpawasutthi Y, Thitikornpong W, Palanuvej C, et al. Chlorogenic acid content, essential oil compositions, and in vitro antioxidant activities of Chromolaena odorata leaves. J Adv Pharm Technol Res. 2016;7:37–42. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R79] [79].Cho KW, Kim YO, Andrade JE, Burgess JR, Kim YC. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor alpha protein expression and decreases plasma triglyceride and adiposity in rats. Eur J Nutr. 2011;50:81–88. [DOI] [PubMed] [Google Scholar]

[R80] [80].Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 2014;5:404–417. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R81] [81].Okla M, Kang I, Kim DM, et al. Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms. J Nutr Biochem. 2015;26:82–90. [DOI] [PubMed] [Google Scholar]

[R82] [82].Padma VV, Lalitha G, Shirony NP, et al. Effect of quercetin against lindane induced alterations in the serum and hepatic tissue lipids in Wistar rats. Asian Pac J Trop Biomed. 2012;2:910–915. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R83] [83].Wan CW, Wong CN, Pin WK, et al. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemicrats induced with a high-cholesterol diet. Phytother Res. 2013;27:545–551. [DOI] [PubMed] [Google Scholar]

[R84] [84].Snyder SM, Zhao B, Luo T, et al. Consumption of quercetin and quercetin-containing apple and cherry extracts affects blood glucose concentration, hepatic metabolism, and gene expression patterns in obese C57BL/6J high fat-fed mice. J Nutr. 2016;146:1001–1007. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R85] [85].Leng L, Xiao Y, Mo Z, et al. Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells. BMC Complement Altern Med. 2018;18:122.doi: 10.1186/s12906-018-2189-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R86] [86].Le Grimellec C, Friedlander G, El Yandouzi EH, Zlatkine P, Giocondi MC. Membrane fluidity and transport properties in epithelia. Kidney Int. 1992;42:825–836. [DOI] [PubMed] [Google Scholar]

[R87] [87].Bastiaanse EML, Höld KM, Van der Laarse A. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res. 1997;33:272–283. [DOI] [PubMed] [Google Scholar]

[R88] [88].Yeagle PL. Yeagle PL. The roles of cholesterol in the biology of cells. The Structure of Biological Membranes. 3rd edBoca Raton: CRC Press; 2012;119–129. [Google Scholar]

[R89] [89].Balut C, Steels P, Radu M, Ameloot M, Driessche WV, Jans D. Membrane cholesterol extraction decreases Na⁺ transport in A6 renal epithelia. Am J Physiol Cell Physiol. 2006;290:C87–C94. [DOI] [PubMed] [Google Scholar]

[R90] [90].Grebowski J, Krokosz A, Puchala M. Membrane fluidity and activity of ATPases in human erythrocytes under the influence of polyhydroxylated fullerene. Biochim Biophys Acta. 2013;1828:241–248. [DOI] [PubMed] [Google Scholar]

[R91] [91].Krokosz A, Grebowski J. Chakraborti S, Dhalla NS. Activity of membrane ATPases in human erythrocytes under the influence of highly hydroxylated fullerenol. Regulation of Membrane Na⁺,K⁺-ATPase, Advances in Biochemistry in Health and Disease 15. Switzerland: Springer International Publishing; 2016;159–172. [Google Scholar]

[R92] [92].Garcia A, Lev B, Hossain KR, et al. Cholesterol depletion inhibits Na⁺,K⁺-ATPase activity in a near-native membrane environment. J Biol Chem. 2019;294:5956–5969. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R93] [93].Ma S, Jia R, Li D, et al. Targeting cellular metabolism chemosensitizes the doxorubicin-resistant human breast adenocarcinoma cells. BioMed Res Int. 2015;2015:453986.doi: 10.1155/2015/453986. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R94] [94].Kumar N, Kant R, Maurya PK, et al. Concentration dependent effect of (−)-epicatechin on Na⁺,K⁺-ATPase and Ca²⁺-ATPase inhibition induced by free radicals in hypertensive patients: Comparison with L-ascorbic acid. Phytother Res. 2002;26:1644–1647. [DOI] [PubMed] [Google Scholar]

[R95] [95].Nicotera P, Moore M, Mirabelli F, et al. Inhibition of hepatocyte plasma membrane Ca²⁺-ATPase activity by menadione metabolism and its restoration by thiols. FEBS Lett. 1985;181:149–153. [DOI] [PubMed] [Google Scholar]

[R96] [96].Hanna AD, Lam A, Tham S, Dulhunty AF, Beard NA. Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Mol Pharmacol. 2014;86:438–449. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R97] [97].Paterson CA, Zeng J, Husseini Z, et al. Calcium ATPase activity and membrane structure in clear and cataractous human lenses. Curr Eye Res. 1997;16:333–338. [DOI] [PubMed] [Google Scholar]

[R98] [98].Torliñska T, Grochowalska A. Age-related changes of Na⁺,K⁺-ATPase, Ca²⁺-ATPase and Mg²⁺-ATPase activities in rat brain synaptosomes. J Physiol Pharmacol. 2004;55:457–465. [PubMed] [Google Scholar]

[R99] [99].Patel V, Upaganlawar A, Zalawadia R, et al. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644:160–168. [DOI] [PubMed] [Google Scholar]

[R100] [100].Simão F, Matté A, Matté C, et al. Resveratrol prevents oxidative stress and inhibition of Na⁺,K⁺-ATPase activity induced by transient global cerebral ischemia in rats. J Nutr Biochem. 2011;22:921–928. [DOI] [PubMed] [Google Scholar]

[R101] [101].Conrard L, Tyteca D. Regulation of membrane calcium transport proteins by the surrounding lipid environment. Biomolecules. 2019;9:513.doi: 10.3390/biom9100513. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R102] [102].Sutherland E, Dixon BS, Leffert HL, et al. Biochemical localization of hepatic surface membrane Na⁺,K⁺-ATPase activity depends on membrane lipid fluidity. Proc Natl Acad Sci USA. 1988;85:8673–8677. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R103] [103].Delamere NA, Paterson CA, Borchman D, et al. Calcium transport, Ca²⁺-ATPase, and lipid order in rabbit ocular lens membranes. Am J Physiol. 1991;260 (Pt 1):C731–C737. [DOI] [PubMed] [Google Scholar]

[R104] [104].Mozanti L, Rabini RA, Biagini G, et al. Changes in membrane fluidity and Na⁺,K⁺-ATPase activity during human trophoblast cell culture. Eur J Biochem. 1992;206:881–885. [DOI] [PubMed] [Google Scholar]

[R105] [105].Wong-Ekkabut J, Xu Z, Triampo W, Tang IM, Tieleman DP, Monticelli L. Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys J. 2007;93:4225–4236. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R106] [106].Cocucci M, Ballarin-Denti A. Effect of polar lipids on ATPase activity of membrane preparations from germinating radish seeds. Plant Physiol. 1981;68:377–381. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R107] [107].Navarro J, Toivio-Kinnucan M, Racker E. Effect of lipid composition on the calcium/adenosine 5’-triphosphate coupling ratio of the Ca²⁺-ATPase of sarcoplasmic reticulum. Biochemistry. 1984;23:130–135. [DOI] [PubMed] [Google Scholar]

[R108] [108].Urbatsch IL, Senior AE. Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein. Arch Biochem Biophys. 1995;316:135–140. [DOI] [PubMed] [Google Scholar]

[R109] [109].Glynn IM. Martonosi A. The Na, K-transporting adenosine triphosphatase. The Enzymes of Biological Membranes. 2nd edNew York, NY: Plenum; 1993;35–114. [Google Scholar]

[R110] [110].Huang B, Blanco G, Mercer RW, et al. Human corneal endothelial cell expression of Na⁺,K⁺-adenosine triphosphatase isoforms. Arch Ophthalmol. 2003;121:840–845. [DOI] [PubMed] [Google Scholar]

[R111] [111].Alexander RT, Beggs MR, Zamani R, et al. Ultrastructural and immunohistochemical localization of plasma membrane Ca²⁺-ATPase 4 in Ca²⁺-transporting epithelia. Am J Physiol Renal Physiol. 2015;309:F604–F616. [DOI] [PubMed] [Google Scholar]

[R112] [112].Stafford N, Wilson C, Oceandy D, et al. The plasma membrane calcium ATPases and their role as major new players in human disease. Physiol Rev. 2017;97:1089–1125. [DOI] [PubMed] [Google Scholar]

[R113] [113].Rodriguez de Sotillo DV, Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem. 2002;13:717–726. [DOI] [PubMed] [Google Scholar]

[R114] [114].Bialecki RA, Tulenko TN. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am J Physiol. 1989;257 (Pt 1):C306–C314. [DOI] [PubMed] [Google Scholar]

[R115] [115].Tulenko TN, Bialecki R, Gleason M. Colatsky T, et al. Ion channels, membrane lipids and cholesterol: a role for membrane lipid domains in arterial function. Potassium Channels: Basic Function and Therapeutic Aspects. New York: Alan R Liss; 1990;187–203. [PubMed] [Google Scholar]

[R116] [116].Gleason MM, Medow MS, Tulenko TN. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res. 1991;69:216–227. [DOI] [PubMed] [Google Scholar]

[R117] [117].Ortega A, Mas-Oliva J. Cholesterol effect on enzyme activity of the sarcolemmal Ca²⁺,Mg²⁺-ATPase from cardiac muscle. Biochim Biophys Acta. 1984;773:231–236. [DOI] [PubMed] [Google Scholar]

[R118] [118].Mas-Oliva J, Delgado-Coello B. Protein stability and the evolution of the cell membrane. Comp Biochem Physiol C Toxicol Pharmacol. 2007;146:207–213. [DOI] [PubMed] [Google Scholar]

[R119] [119].Doneen BA. High affinity calcium/magnesium ATPase in kidney of euryhaline Gillichthys mirabilis: kinetics, subcellular distribution and effect of salinity. Comp Biochem Physiol. 1993;106B:719–728. [Google Scholar]

[R120] [120].Strehler EE, Caride AJ, Filoteo AG, et al. Plasma membrane Ca²⁺ATPases as dynamic regulators of cellular calcium handling. Ann N Y Acad Sci. 2007;1099:226–236. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R121] [121].Di Leva F, Domi T, Fedrizzi L, Lim D, Carafoli E. The plasma membrane Ca²⁺ ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys. 2008;476:65–74. [DOI] [PubMed] [Google Scholar]

[R122] [122].Vasic VM, Colovic BM, Krstic DZ. Mechanism of Na⁺/K⁺-ATPase and Mg²⁺-ATPase inhibition by metal ions and complexes. Hem Ind. 2009;63:499–509. [Google Scholar]

[R123] [123].Brini M, Carafoli E. The plasma membrane Ca²⁺ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol. 2011;3:a004168.doi: 10.1101/cshperspect.a004168. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R124] [124].Strehler EE. Plasma membrane calcium ATPases as novel candidates for therapeutic agent development. J Pharm Pharm Sci. 2013;16:190–206. [DOI] [PMC free article] [PubMed] [Google Scholar]

[R125] [125].Penniston JT, Padanyi R, Paszty K, et al. Apart from its known function, the plasma membrane Ca²⁺ ATPase can regulate Ca²⁺ signaling by controlling phosphatidylinositol 4,5-bisphosphate levels. J Cell Sci. 2014;127:72–84. [DOI] [PubMed] [Google Scholar]

[R126] [126].Álvarez JAL, Murillo TCL, Nestor CAV. Najman S, et al. Epithelial Na⁺,K⁺-ATPase—a sticky pump. Cell biology—New Insights. Croatia: IntechOpen; 2016;29–57. [Google Scholar]

[R127] [127].Obradovic M, Stanimirovic J, Panic A. Choi S, et al. Na+/K+-ATPase. Encyclopedia of Signaling Molecules. Switzerland: Springer; 2018;3338–3343. [Google Scholar]

PERMALINK

Moderation of doxorubicin-induced nephrotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens

Catherine C Ikewuchi, PhD

Mercy O Ifeanacho, PhD

Jude C Ikewuchi, PhD

Abstract

Background:

Methods:

Results:

Conclusions:

Introduction

Materials and methods

Procurement of materials

Preparation of extracts

Experimental design and sample collection

Assay of biochemical parameters

Determination of per cent protection

Statistical analysis of data

Results

Figure 1.

Table 1.

Figure 2.

Table 2.

Table 3.

Table 4.

Discussion

Data accessibility statement

Competing interests

Funding

References

Associated Data

Data Availability Statement

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Moderation of doxorubicin-induced nephrotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens

Catherine C Ikewuchi, PhD

Mercy O Ifeanacho, PhD

Jude C Ikewuchi, PhD

Abstract

Background:

Methods:

Results:

Conclusions:

Introduction

Materials and methods

Procurement of materials

Preparation of extracts

Experimental design and sample collection

Assay of biochemical parameters

Determination of per cent protection

Statistical analysis of data

Results

Figure 1.

Table 1.

Figure 2.

Table 2.

Table 3.

Table 4.

Discussion

Data accessibility statement

Competing interests

Funding

References

Associated Data

Data Availability Statement

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases